Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Breathe easy while saving the ozone layer.

[No authors listed]

Johns Hopkins Med Lett Health After 50. 2013 Aug;25(7):8. No abstract available.

PMID:
24396890
2.

A new beginning: making way for CFC-free inhalers.

Weller T.

Community Nurse. 1998 Nov;4(10):23-4. No abstract available.

PMID:
10326377
3.

The effect of ozone and PM10 on hospital admissions for pneumonia and chronic obstructive pulmonary disease: a national multicity study.

Medina-Ramón M, Zanobetti A, Schwartz J.

Am J Epidemiol. 2006 Mar 15;163(6):579-88. Epub 2006 Jan 27.

4.

Use of ozone-depleting substances; removal of essential-use designation (flunisolide, etc.). Final rule.

Food and Drug Administration, HHS.

Fed Regist. 2010 Apr 14;75(71):19213-41.

5.

Public health: Where there's smoke.

Hughes V.

Nature. 2012 Sep 27;489(7417):S18-20. doi: 10.1038/489S18a. No abstract available.

PMID:
23013712
6.

[Combination therapy with inhaled bronchodilators in chronic obstructive pulmonary disease].

Shen N, Cai BQ, Yao WZ.

Zhonghua Jie He He Hu Xi Za Zhi. 2008 Oct;31(10):766-7. Review. Chinese. No abstract available.

PMID:
19080604
7.

Respiratory procedures. Part 3--use of a nebuliser.

Jevon P, Humphrey N.

Nurs Times. 2007 Aug 21-27;103(34):24-5. No abstract available.

PMID:
17850000
8.

Effects of air pollution on adults with chronic obstructive pulmonary disease.

Desqueyroux H, Pujet JC, Prosper M, Le Moullec Y, Momas I.

Arch Environ Health. 2002 Nov-Dec;57(6):554-60.

PMID:
12696653
9.

Inhalation therapy: help patients avoid these mistakes.

Self TH, Wallace JL, George CM, Howard-Thompson A, Schrock SD.

J Fam Pract. 2011 Dec;60(12):714-21. Review. No abstract available.

PMID:
22163353
10.

Training tools for inhalation devices: the need for more sophistication.

Azouz W, Campbell J, Chrystyn H.

Prim Care Respir J. 2011 Jun;20(2):221. doi: 10.4104/pcrj.2011.00036. No abstract available.

11.

[Guidelines for the clinical management of COPD. Prevention and reduction of risk factors].

SPLF. Société de Pneumologie de Langue Française.

Rev Mal Respir. 2003 Jun;20(3 Pt 2):S28-31. French. No abstract available.

PMID:
12910091
12.

Ozone depletion: causes, potential effects and remedies.

Miller BJ, Bogle SP.

Hawaii Med J. 1993 May;52(5):118-9, 122, 131.

PMID:
8320088
13.

Canada and US finalise ozone agreement.

[No authors listed]

J Environ Monit. 2000 Dec;2(6):93N. No abstract available.

PMID:
11296762
14.

Smoking cessation and environmental hygiene.

Pirozzi C, Scholand MB.

Med Clin North Am. 2012 Jul;96(4):849-67. doi: 10.1016/j.mcna.2012.04.014. Epub 2012 Jun 12. Review.

PMID:
22793948
15.

[Inhalation therapy for cough disorders: methods and techniques].

Berzel HG, Berzel SG.

Pharm Unserer Zeit. 2008;37(6):500-7. doi: 10.1002/pauz.200800290. Review. German. No abstract available.

PMID:
18956372
16.

Change in the air. Banning CFC-driven inhalers could levy a toll on asthma sufferers.

Harrison E.

Sci Am. 2008 Aug;299(2):20, 22. No abstract available.

PMID:
18666671
17.

Not quite a breath of fresh air: use of combination inhalers in COPD.

Stabler S, Tejani AM, Bruchet N.

Can Fam Physician. 2012 Feb;58(2):149-50. No abstract available.

18.

Toward better COPD management: practical aspects of inhaler use.

Garvey C, Ortiz G, Yawn BP.

Adv NPs PAs. 2011 Aug;2(8):27-30, 32. Review. No abstract available.

PMID:
21853640
19.

Trends in chronic obstructive pulmonary disease in the Asia-Pacific regions.

Tan WC.

Curr Opin Pulm Med. 2011 Mar;17(2):56-61. doi: 10.1097/MCP.0b013e32834316cd. Review.

PMID:
21178626
20.

Phaseout of chlorofluorocarbons (CFCs) in metered-dose inhalers. Highlights of the Canadian initial transition strategy.

D'Urzo AD, D'Urzo DK.

Can Fam Physician. 1999 Jun;45:1544-6, 1556-7. English, French. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk